Tudor Investment Corp

Tudor Investment Corp’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Tudor Investment Corp’s Portfolio JNCE Stock Details JNCE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$5.85M	Buy
2017 Q2	–	Sell
2017 Q1	$2.2M	Buy